Release Date: 22/11/13 17:24 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 155.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%